Neurological
-
Molecular imaging technology has shown the crucial role maternal vitamin D levels play in the early development of the brain cells that produce dopamine. The finding provides a greater understanding of the mechanisms underlying schizophrenia.
-
There may be new hope for people afflicted with Tourette's syndrome, in the form of a wrist-worn device. In a test of the technology, the majority of participants experienced a reduction in tic severity of at least 25%.
-
Scientists have developed a new technique that could eventually lead to new potential treatments for Alzheimer’s disease. The team investigated a compound that breaks down a protein associated with the disease, with tests in mice improving symptoms.
-
Scientists have a good understanding of how brain circuitry is affected by epilepsy, but not a lot is known about how epilepsy affects behavior. A new study has used AI on mice to catch epilepsy-related behavior that can be missed by the human eye.
-
It sounds like a sci-fi movie scene, but scientists have successfully created electrodes in living tissue using a viscous gel of enzymes. It could signal a fresh approach to bioelectronics and, in the future, new therapies for neurological disorders.
-
Investigating ways to head off the chain of events that leads to multiple sclerosis, researchers have found a chemical regulator in mice that causes the inflammatory cascade associated with the disease. They also figured out how to switch it off.
-
The anticonvulsant properties of cannabidiol (CBD) are well-known; however, a new study has highlighted a previously unknown way that CBD reduces seizures in those with treatment-resistant epilepsy.
-
Mini human brains, grown from stem cells and implanted into living mice, have for the first time been shown to respond to things the mice were seeing. Scientists were able to watch the responses in real time thanks to specialized graphene electrodes.
-
New research presents the most comprehensive study to date into the long-term neurological problems associated with COVID-19. Tracking 150,000 COVID patients for a year the research found COVID led to a 42% increase in risk of several brain disorders.
-
A study has found COVID-19 nearly doubles a person’s risk of developing Alzheimer’s disease in the year following infection. The findings add to a body of research indicating SARS-CoV-2 infections can affect progression of neurodegenerative disease.
-
A hormone released by muscles during exercise has been found to reduce levels of a protein associated with Parkinson’s disease. The promising animal study indicates future therapies may be developed based on the way this hormone improves brain health.
-
We all know a good, long walk in nature can be relaxing, but a landmark new study offers some of the first causal evidence to show exactly how a one-hour walk in the forest reduces activity in brain areas responsible for processing stress.
Load More